Newbridge Financial Services Group, Inc. Invitae Corp Transaction History

Newbridge Financial Services Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$2.13 - $9.01 $2,709 - $11,460	-1,272 Reduced 62.02%	779 $2,000
Q1 2022 Apr 26, 2022	BUY	$6.28 - $15.59 $4,697 - $11,661	748 Added 57.41%	2,051 $16,000
Q4 2021 Jan 19, 2022	BUY	$14.7 - $28.67 $19,154 - $37,357	1,303 New	1,303 $20,000
Q3 2021 Oct 27, 2021	SELL	$24.31 - $33.6 $5,712 - $7,896	-235 Closed	0 $0
Q1 2021 Sep 07, 2021	SELL	$33.06 - $56.93 $169,101 - $291,196	-5,115 Reduced 95.61%	235 $9,000

Q4 2020 Sep 07, 2021	BUY	$39.09 - $57.4 $35,454 - $52,061	907 Added 20.41%	5,350 $224,000
Q3 2020 Sep 07, 2021	BUY	$28.43 - $44.67 $126,314 - $198,468	4,443 New	4,443 $193,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.